Provided by Tiger Fintech (Singapore) Pte. Ltd.

Clearmind Medicine, Inc.

1.03
0.0000
Post-market: 1.02-0.0099-0.96%19:41 EDT
Volume:51.12K
Turnover:52.71K
Market Cap:5.29M
PE:-0.91
High:1.08
Open:1.03
Low:1.02
Close:1.03
Loading ...

Psychedelic: Clearmind completes site initiation for CMND-100 trial

TIPRANKS
·
24 Jul

Clearmind Medicine completes initiation at TASMC for Phase I/IIa trial

TIPRANKS
·
23 Jul

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

GlobeNewswire
·
23 Jul

Clearmind Medicine Inc. Expands Clinical Trial for CMND-100 in Alcohol Use Disorder with New Site at Johns Hopkins University

Reuters
·
15 Jul

Clearmind Medicine Gets Approval for Alcohol Use Disorder Clinical Trial in Israel

MT Newswires Live
·
03 Jul

Clearmind Medicine announces IRB approval for Phase 1/2a trial for AUD

TIPRANKS
·
03 Jul

Clearmind Medicine Inc. Doses First Participant in Groundbreaking Clinical Trial for Alcohol Use Disorder Treatment

Reuters
·
01 Jul

Clearmind Medicine announces first participant ever dosed with CMND-100

TIPRANKS
·
30 Jun

Clearmind Adds New Site to Trial for Experimental Alcohol Use Disorder Drug

MT Newswires Live
·
27 Jun

Clearmind Medicine expands global clinical trial targeting AUD market

TIPRANKS
·
27 Jun

BRIEF-Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

Reuters
·
25 Jun

Clearmind Medicine Expands Alcohol Use Disorder Clinical Trial with Addition of Tel Aviv Sourasky Medical Center

Reuters
·
23 Jun

Clearmind Medicine Enrolls First Patient in Study of Potential Alcohol Abuse Treatment

MT Newswires Live
·
05 Jun

Psychedelic: Clearmind completes clinical site initiations for AUD trial

TipRanks
·
25 Apr

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

GlobeNewswire
·
25 Apr

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

GlobeNewswire
·
25 Apr

BRIEF-Clearmind Medicine Completes The Initiation Of Its Alcohol Use Disorder Phase I/IIA Clinical Trial At All Current Clinical Sites

Reuters
·
23 Apr

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

GlobeNewswire
·
23 Apr

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

GlobeNewswire
·
21 Apr

BRIEF-Clearmind Medicine Receives Notice Of Allowance For United States Patent Covering Binge Behavior

Reuters
·
17 Apr